Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress. | Curr Oncol | 2022 | 36290903 | PubTator, text mining | PubMed |
| Potential of Epidermal Growth Factor-like Peptide from the Sea Cucumber Stichopus horrens to Increase the Growth of Human Cells: In Silico Molecular Docking Approach. | Mar Drugs | 2022 | 36286420 | PubTator, text mining | PubMed |
| Extrusion of Cell Encapsulated in Boron Nitride Nanotubes Reinforced Gelatin-Alginate Bioink for 3D Bioprinting. | Gels | 2022 | 36286104 | PubTator, text mining | PubMed |
Evaluation of the Regenerative Potential of Platelet-Lysate and Platelet-Poor Plasma Derived from the Cord Blood Units in Corneal Wound Healing Applications: An In Vitro Comparative Study on Corneal Epithelial Cells. | Curr Issues Mol Biol | 2022 | 36286018 | PubTator, text mining | PubMed |
| Integrative analysis of macrophage ribo-Seq and RNA-Seq data define glucocorticoid receptor regulated inflammatory response genes into distinct regulatory classes. | Comput Struct Biotechnol J | 2022 | 36284713 | PubTator, text mining | PubMed |
| Immune cell infiltration-related clinical diagnostic model for Ankylosing Spondylitis. | Front Genet | 2022 | 36263434 | PubTator, text mining | PubMed |
| Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer. | Int J Biol Sci | 2022 | 36263185 | PubTator, text mining | PubMed |
| Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline. | Front Oncol | 2022 | 36249063 | PubTator, text mining | PubMed |
| Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor Cells. | Int J Mol Sci | 2022 | 36233320 | PubTator, text mining | PubMed |
| Effects of Noonan Syndrome-Germline Mutations on Mitochondria and Energy Metabolism. | Cells | 2022 | 36231062 | PubTator, text mining | PubMed |
| Protein tyrosine kinase 6 regulates activation of SRC kinase. | J Biol Chem | 2022 | 36228719 | PubTator, text mining | PubMed |
| A statistical physics approach for disease module detection. | Genome Res | 2022 | 36220609 | PubTator, text mining | PubMed |
| Identification of the Hub Genes and Potential Regulation Network in Chronic Hepatitis B via Bioinformatics Analysis. | Dis Markers | 2022 | 36193503 | PubTator, text mining | PubMed |
| Multi-context genetic modeling of transcriptional regulation resolves novel disease loci. | Nat Commun | 2022 | 36171194 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure. | World J Gastroenterol | 2022 | 36161038 | PubTator, text mining | PubMed |
| The role of miR-200 family in the regulation of hallmarks of cancer. | Front Oncol | 2022 | 36158660 | PubTator, text mining | PubMed |
| Genomic study of nonsyndromic hearing loss in unaffected individuals: Frequency of pathogenic and likely pathogenic variants in a Brazilian cohort of 2,097 genomes. | Front Genet | 2022 | 36147510 | PubTator, text mining | PubMed |
| Recent Development of the Molecular and Cellular Mechanisms of Hydrogen Sulfide Gasotransmitter. | Antioxidants (Basel) | 2022 | 36139861 | PubTator, text mining | PubMed |
| Systematic Analysis of Genetic and Pathway Determinants of Eribulin Sensitivity across 100 Human Cancer Cell Lines from the Cancer Cell Line Encyclopedia (CCLE). | Cancers (Basel) | 2022 | 36139690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=17